Literature DB >> 23065526

Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy.

Mario Tiribelli, Dora Fabbro, Alessandra Franzoni, Renato Fanin, Giuseppe Damante, Daniela Damiani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23065526      PMCID： PMC3659940          DOI： 10.3324/haematol.2012.075895

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  Catalog of 605 single-nucleotide polymorphisms (SNPs) among 13 genes encoding human ATP-binding cassette transporters: ABCA4, ABCA7, ABCA8, ABCD1, ABCD3, ABCD4, ABCE1, ABCF1, ABCG1, ABCG2, ABCG4, ABCG5, and ABCG8.

Authors:  Aritoshi Iida; Susumu Saito; Akihiro Sekine; Chihiro Mishima; Yuri Kitamura; Kimei Kondo; Satoko Harigae; Saori Osawa; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2002       Impact factor: 3.172

2.  Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemia.

Authors:  Fang Wang; Yong-ju Liang; Xing-ping Wu; Li-ming Chen; Kenneth Kin Wah To; Chun-ling Dai; Yan-yan Yan; Yan-sheng Wang; Xiu-zhen Tong; Li-wu Fu
Journal:  Eur J Cancer       Date:  2011-04-29       Impact factor: 9.162

3.  C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Authors:  Yasuo Imai; Minoru Nakane; Kumie Kage; Satomi Tsukahara; Etsuko Ishikawa; Takashi Tsuruo; Yoshio Miki; Yoshikazu Sugimoto
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

4.  ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations.

Authors:  K-A Kim; H-J Joo; J-Y Park
Journal:  J Clin Pharm Ther       Date:  2010-12       Impact factor: 2.512

5.  Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia.

Authors:  Shalaka S Hampras; Lara Sucheston; Joli Weiss; Maria R Baer; Gary Zirpoli; Prashant K Singh; Meir Wetzler; Raj Chennamaneni; Javier G Blanco; Laurieann Ford; Kirsten B Moysich
Journal:  Int J Mol Epidemiol Genet       Date:  2010-05-20

6.  Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

Authors:  Zineb Benderra; Anne-Marie Faussat; Lydia Sayada; Jean-Yves Perrot; Driss Chaoui; Jean-Pierre Marie; Ollivier Legrand
Journal:  Clin Cancer Res       Date:  2004-12-01       Impact factor: 12.531

7.  The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype.

Authors:  Daniela Damiani; Mario Tiribelli; Elisabetta Calistri; Antonella Geromin; Alexsia Chiarvesio; Angela Michelutti; Margherita Cavallin; Renato Fanin
Journal:  Haematologica       Date:  2006-05-16       Impact factor: 9.941

Review 8.  Pharmacogenomics of ABC transporters and its role in cancer chemotherapy.

Authors:  Alex Sparreboom; Romano Danesi; Yuichi Ando; Juliana Chan; William D Figg
Journal:  Drug Resist Updat       Date:  2003-04       Impact factor: 18.500

9.  Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

Authors:  Charis P Zamber; Jatinder K Lamba; Kazuto Yasuda; Jennifer Farnum; Kenneth Thummel; John D Schuetz; Erin G Schuetz
Journal:  Pharmacogenetics       Date:  2003-01

Review 10.  ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance.

Authors:  Susan D P W M de Jonge-Peeters; Folkert Kuipers; Elisabeth G E de Vries; Edo Vellenga
Journal:  Crit Rev Oncol Hematol       Date:  2007-03-23       Impact factor: 6.312
  10 in total
  3 in total

Review 1.  Predicting Chemotherapy Resistance in AML.

Authors:  Cecilia C S Yeung; Jerald Radich
Journal:  Curr Hematol Malig Rep       Date:  2017-12       Impact factor: 3.952

Review 2.  Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.

Authors:  Juan Eduardo Megías-Vericat; David Martínez-Cuadrón; Antonio Solana-Altabella; José Luis Poveda; Pau Montesinos
Journal:  Pharmaceutics       Date:  2022-04-17       Impact factor: 6.525

Review 3.  The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy.

Authors:  Jose J G Marin; Maria J Monte; Alba G Blazquez; Rocio I R Macias; Maria A Serrano; Oscar Briz
Journal:  Acta Pharmacol Sin       Date:  2013-12-09       Impact factor: 6.150
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.